Home   /   Pressrelease    /   

XVIVO Perfusion AB admitted to...

XVIVO Perfusion AB admitted to trading on Nasdaq First North Premier

As previously announced, XVIVO Perfusion AB (publ) (the "Company" or " Xvivo Perfusion ") has decided to apply for listing of XVIVO Perfusion’s shares on Nasdaq First North Premier as part of preparing the company for listing on the Nasdaq Stockholm's main list. Nasdaq has approved the Company's application and the first day of trading in XVIVO Perfusion’s shares on Nasdaq First North Premier will be 8 February 2016. The company's shares will continue trading with the same short name and ISIN code.

February 5, 2016
Gothenburg
XVIVO Perfusion AB (publ)

Fill out the form to watch the video